AOD-9604

Buy AOD-9604 Online

AOD-9604 is a modified peptide fragment of human growth hormone that has attracted attention for its effects on fat metabolism, lipolysis, and body composition. It has been investigated extensively in metabolic and obesity-related research.

Product Information

AOD-9604 is based on the C-terminal region of human growth hormone and was developed specifically to investigate the fat-metabolizing effects of this region without recapitulating all the actions of full-length growth hormone. Research has focused particularly on lipolysis and changes in body weight and fat mass.

How It Works

AOD-9604 appears to influence fat metabolism by promoting lipolysis and increasing the body's ability to mobilize stored fat. Animal research has also linked its activity with changes in beta-adrenergic signaling and energy expenditure.

POTENTIAL BENEFITS

1. Fat-Metabolism Research

AOD-9604 has been extensively studied for its ability to influence the breakdown of stored fat. Animal studies have demonstrated increased lipolytic activity and reductions in body fat.

2. Body-Weight Research

Research in obese animal models has reported reductions in body-weight gain following AOD-9604 administration, making it particularly interesting for metabolic and weight-management research.

3. Lipolysis

One of the primary research interests surrounding AOD-9604 is its ability to promote lipolysis—the process by which stored triglycerides are broken down and made available for energy.

4. Metabolic Research

AOD-9604 has been investigated in relation to energy expenditure, fat oxidation, and metabolic signaling, giving it broader research interest beyond simple body-weight measurements.

5. Bone & Cartilage Research

AOD-9604 has also been investigated in preclinical models for potential effects on bone and cartilage biology, although this area remains considerably less established than its metabolic research.

Dosage

Human clinical studies investigated oral doses ranging from approximately 0.25–30 mg/day, while early studies also examined other routes of administration. There is no validated therapeutic dose for general use. Community sources commonly discuss approximately 250–500 mcg/day subcutaneously, but this is anecdotal rather than an established clinical regimen.

Side Effects

Clinical research has reported headache, nausea, diarrhea, flatulence, and increased appetite among reported adverse events, although many events were mild or moderate.

References

• Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001;142(12):5182-5189. PMID: 11713213.
• Orlovius AK, et al. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug Test Anal. 2013. PMID: 24124033.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.